首页 | 本学科首页   官方微博 | 高级检索  
     


Extensor digitorum brevis test and resistance to botulinum toxin type A
Authors:Gordon Paul H  Gooch Clifton L  Greene Paul E
Affiliation:Department of Neurology, ACC-2, University of New Mexico, 915 Camino de Salud NE, Albuquerque, New Mexico 87131, USA. pgordon@salud.unm.edu
Abstract:We studied 22 patients with dystonia to determine the normal range of values for the extensor digitorum brevis (EDB) test, and to determine its sensitivity and specificity in detecting resistance to botulinum toxin type A (BTX-A). Three compound muscle action potentials (CMAPs) elicited by peroneal nerve stimulation were averaged before and 2 weeks after injection of 20 units of BTX-A into the EDB. Amplitude and area ratios were calculated by dividing the averaged postinjection CMAP by the averaged preinjection CMAP values. The difference in means of this ratio between clinically sensitive and resistant subjects was statistically significant (P < 0.002). A normal range of <0.45 for each ratio was determined by adding two standard deviations to the ratio mean of 14 clinically sensitive subjects. Four of five resistant patients had values outside the normal range. The EDB test is a simple quantitative method of detecting resistance to BTX-A, with a sensitivity of 80% and specificity of 94%.
Keywords:botulinum toxin  EDB test  immunoresistance  nerve conduction studies
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号